blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2694463

EP2694463 - TREATING CENTRAL NERVOUS SYSTEM TUMORS WITH COENZYME Q10 [Right-click to bookmark this link]
Former [2014/07]METHODS OF TREATING CENTRAL NERVOUS SYSTEM TUMORS
[2019/16]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 11.05.2024
FormerThe patent has been granted
Status updated on  02.08.2019
FormerGrant of patent is intended
Status updated on  14.04.2019
FormerExamination is in progress
Status updated on  29.09.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Berg LLC
500 Old Connecticut Path, Building B
Framingham, MA 01701 / US
[2019/39]
Former [2014/07]For all designated states
Berg LLC
1845 Elm Hill Pike
Nashville, TN 37210 / US
Inventor(s)01 / JIMENEZ, Joaquin, J.
621 Southwest 78th Court
Miami, FL 33144 / US
02 / NARAIN, Niven, Rajin
73 Fresh Pond Parkway
Cambridge, MA 02138 / US
03 / SARANGARAJAN, Rangaprasad
454 Central Street
Boylston, MA 01505 / US
04 / MCCOOK, John, Patrick
4913 Southern Hills Drive
Frisco, TX 75034 / US
 [2014/07]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2019/36]
Former [2014/07]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12767439.804.04.2012
[2019/36]
WO2012US32178
Priority number, dateUS201161471659P04.04.2011         Original published format: US 201161471659 P
[2014/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012138765
Date:11.10.2012
Language:EN
[2012/41]
Type: A1 Application with search report 
No.:EP2694463
Date:12.02.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 11.10.2012 takes the place of the publication of the European patent application.
[2014/07]
Type: B1 Patent specification 
No.:EP2694463
Date:04.09.2019
Language:EN
[2019/36]
Type: B8 Corrected title page of specification 
No.:EP2694463
Date:09.10.2019
[2019/41]
Search report(s)International search report - published on:US11.10.2012
(Supplementary) European search report - dispatched on:EP30.09.2014
ClassificationIPC:A61K31/122, A61P35/00, A61P35/02
[2014/44]
CPC:
A61K31/122 (EP,CN,KR,US); A61K31/12 (KR); A61P1/08 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/04 (EP); A61P25/06 (EP); A61P25/18 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P27/10 (EP);
A61P27/16 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P35/04 (EP) (-)
C-Set:
A61K31/122, A61K2300/00 (EP,US)
Former IPC [2014/07]C07C50/04, A61K31/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/07]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BEHANDLUNG VON TUMOREN IM ZENTRALNERVENSYSTEM MIT COENZYM Q10[2019/16]
English:TREATING CENTRAL NERVOUS SYSTEM TUMORS WITH COENZYME Q10[2019/16]
French:TRAITEMENT DE TUMEURS DU SYSTÈME NERVEUX CENTRAL AVEC COENZYME Q10[2019/16]
Former [2014/07]VERFAHREN ZUR BEHANDLUNG VON TUMOREN IM ZENTRALNERVENSYSTEM
Former [2014/07]METHODS OF TREATING CENTRAL NERVOUS SYSTEM TUMORS
Former [2014/07]MÉTHODES DE TRAITEMENT DE TUMEURS DU SYSTÈME NERVEUX CENTRAL
Entry into regional phase04.11.2013National basic fee paid 
04.11.2013Search fee paid 
04.11.2013Designation fee(s) paid 
04.11.2013Examination fee paid 
Examination procedure04.11.2013Examination requested  [2014/07]
27.04.2015Amendment by applicant (claims and/or description)
29.09.2017Despatch of a communication from the examining division (Time limit: M06)
09.04.2018Reply to a communication from the examining division
02.08.2018Despatch of a communication from the examining division (Time limit: M02)
02.10.2018Reply to a communication from the examining division
15.04.2019Communication of intention to grant the patent
23.07.2019Fee for grant paid
23.07.2019Fee for publishing/printing paid
23.07.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.09.2017
Opposition(s)05.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
28.04.2014Renewal fee patent year 03
27.04.2015Renewal fee patent year 04
27.04.2016Renewal fee patent year 05
27.04.2017Renewal fee patent year 06
27.04.2018Renewal fee patent year 07
29.04.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.04.2012
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MK04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
IE04.04.2020
LU04.04.2020
BE30.04.2020
CH30.04.2020
LI30.04.2020
[2022/32]
Former [2022/27]HU04.04.2012
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
IE04.04.2020
LU04.04.2020
BE30.04.2020
CH30.04.2020
LI30.04.2020
Former [2022/26]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
IE04.04.2020
LU04.04.2020
BE30.04.2020
CH30.04.2020
LI30.04.2020
Former [2021/20]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
IE04.04.2020
LU04.04.2020
BE30.04.2020
CH30.04.2020
LI30.04.2020
Former [2021/12]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
LU04.04.2020
BE30.04.2020
CH30.04.2020
LI30.04.2020
Former [2021/08]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
LU04.04.2020
CH30.04.2020
LI30.04.2020
Former [2020/52]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/37]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/36]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/27]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/25]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/23]AL04.09.2019
AT04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
Former [2020/22]AL04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
Former [2020/20]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/15]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/11]FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/10]FI04.09.2019
LT04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
Former [2020/09]FI04.09.2019
LT04.09.2019
NO04.12.2019
Former [2020/08]LT04.09.2019
NO04.12.2019
Documents cited:Search[XY]WO2005069916  (UNIV MIAMI [US], et al) [X] 1,4,9,10 * pages 8,10; claims 8-22 * [Y] 1-18;
 [XY]EP1908459  (KANEKA CORP [JP], et al) [X] 1,4,9,10 * paragraph [0040]; claim - * [Y] 1-18;
 [XY]US2011027247  (NARAIN NIVEN RAJIN [US], et al) [X] 1,4,9,10 * example -; claims 26,27 * [Y] 1-18;
 [XP]WO2011112900  (CYTOTECH LABS LLC [US], et al) [XP] 1,4,9,10* paragraph [0193] *
International search[X]US2008287541  (HOFFMAN ARNOLD [IL], et al);
 [Y]US2010209388  (MAZZIO ELIZABETH ANNE [US], et al);
 [Y]  - "Fact Sheet: Brain Tumor", LOS ANGELES CAREGIVER RESOURCE CENTER, (2004), pages 1 - 12, URL: http://lacrc.usc.edu/forms/braintumor.pdf, (20120619), XP008172098
ExaminationUS2009005398
by applicantWO2005069916
 EP1908459
 WO2008116135
 WO2009126764
 WO2010132507
 US2011027247
 WO2011112900
    - POTSCHKA et al., Journal of Pharm. and Exp. Therapeutics, (20030700), vol. 306, no. 1, pages 124 - 131
    - NEGLIA et al., NEJM, (19910000), vol. 325, pages 1330 - 1336
    - TAYLOR et al., J Clin Oncol, (20100000), vol. 28, pages 5287 - 5293
    - WALTER et al., J Clin Oncol., (19980000), vol. 16, pages 3761 - 3767
    - HIJIYA et al., JAMA, (20070000), vol. 297, pages 1207 - 1215
    - ZAMORE, P.D. et al., Cell, (20000000), vol. 101, pages 25 - 33
    - TUSCHL, T. et al., Genes Dev., (19990000), vol. 13, pages 3191 - 3197
    - COTTRELL TR; DOERING TL., Trends Microbiol., (20030000), vol. 11, pages 37 - 43
    - BUSHMAN F., Mol Therapy, (20030000), vol. 7, pages 9 - 10
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.